James initiated coverage on Regenxbio Inc . (NASDAQ:RGNX), bestowing an Outperform rating and setting a price target of $27.00 for the biotechnology company's shares. The firm's endorsement comes with a positive outlook based on several key factors that could influence the company's future performance.

Raymond James lowered the firm’s price target on Corpay (CPAY) to $417 from $434 and keeps an Outperform rating on the shares. Corpay reported

Raymond James analyst David Feaster raised the firm’s price target on Ameris Bancorp (ABCB) to $71 from $67 and keeps an Outperform rating on the

James analyst Patrick O'Shaughnessy updated the financial outlook for Intercontinental Exchange (NYSE:ICE), increasing the price target from $185.00 to $195.00. The firm reiterated its Outperform rating on the stock,

Raymond James analyst John Freeman lowered the firm’s price target on Viper Energy (VNOM) to $58 from $64 and keeps an Outperform rating on the